KR20180044091A - Ginseng containing increased specific ginsenoside and the preparing method thereof - Google Patents
Ginseng containing increased specific ginsenoside and the preparing method thereof Download PDFInfo
- Publication number
- KR20180044091A KR20180044091A KR1020160137742A KR20160137742A KR20180044091A KR 20180044091 A KR20180044091 A KR 20180044091A KR 1020160137742 A KR1020160137742 A KR 1020160137742A KR 20160137742 A KR20160137742 A KR 20160137742A KR 20180044091 A KR20180044091 A KR 20180044091A
- Authority
- KR
- South Korea
- Prior art keywords
- ginseng
- present
- ginsenoside
- content
- heat
- Prior art date
Links
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 100
- 241000208340 Araliaceae Species 0.000 title claims abstract description 98
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 98
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 98
- 229930182494 ginsenoside Natural products 0.000 title claims abstract description 31
- 229940089161 ginsenoside Drugs 0.000 title claims abstract description 20
- 230000001965 increasing effect Effects 0.000 title claims abstract description 14
- 238000000034 method Methods 0.000 title claims description 16
- 238000004519 manufacturing process Methods 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000010438 heat treatment Methods 0.000 claims description 11
- 230000036541 health Effects 0.000 claims description 10
- 235000013376 functional food Nutrition 0.000 claims description 9
- 238000005520 cutting process Methods 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 2
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 241000283707 Capra Species 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- CJFGBCWGOQRURQ-UHFFFAOYSA-N ginsenoside Mc Natural products C1CC(C2(CCC3C(C)(C)C(O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C1O CJFGBCWGOQRURQ-UHFFFAOYSA-N 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 235000017709 saponins Nutrition 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- PYXFVCFISTUSOO-HKUCOEKDSA-N (20S)-protopanaxadiol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@H]([C@@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C PYXFVCFISTUSOO-HKUCOEKDSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 206010019851 Hepatotoxicity Diseases 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000002789 Panax ginseng Nutrition 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- PYXFVCFISTUSOO-UHFFFAOYSA-N betulafolienetriol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC(C(C)(O)CCC=C(C)C)C4C(O)CC3C21C PYXFVCFISTUSOO-UHFFFAOYSA-N 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000007686 hepatotoxicity Effects 0.000 description 2
- 231100000304 hepatotoxicity Toxicity 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000006993 memory improvement Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- SWQINCWATANGKN-UHFFFAOYSA-N protopanaxadiol Natural products CC(CCC=C(C)C)C1CCC2(C)C1C(O)CC1C3(C)CCC(O)C(C)(C)C3CCC21C SWQINCWATANGKN-UHFFFAOYSA-N 0.000 description 2
- BBEUDPAEKGPXDG-UHFFFAOYSA-N protopanaxatriol Natural products CC(CCC=C(C)C)C1CCC2(C)C1C(O)CC3C4(C)CCC(O)C(C)(C)C4C(O)CC23C BBEUDPAEKGPXDG-UHFFFAOYSA-N 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229910052594 sapphire Inorganic materials 0.000 description 2
- 239000010980 sapphire Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- QOMBXPYXWGTFNR-KRPFXEAISA-N (20E)-Ginsenoside F4 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H]2C(C)(C)[C@@H](O)CC[C@]2(C)[C@@H]2[C@](C)([C@@]3(C)[C@H]([C@H](O)C2)[C@@H](/C(=C\C/C=C(\C)/C)/C)CC3)C1)[C@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O1 QOMBXPYXWGTFNR-KRPFXEAISA-N 0.000 description 1
- NJUXRKMKOFXMRX-MHOSXIPRSA-N (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-(6-methylhepta-2,5-dien-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound CC(C)=CCC=C(C)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@@]21C NJUXRKMKOFXMRX-MHOSXIPRSA-N 0.000 description 1
- 241000796654 Axos Species 0.000 description 1
- 241001632410 Eleutherococcus senticosus Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Chemical class C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000003446 memory effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 229920001197 polyacetylene Chemical class 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- SHCBCKBYTHZQGZ-DLHMIPLTSA-N protopanaxatriol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2[C@@H](O)C[C@@]3(C)[C@]4(C)CC[C@H]([C@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C SHCBCKBYTHZQGZ-DLHMIPLTSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/10—General methods of cooking foods, e.g. by roasting or frying
- A23L5/15—General methods of cooking foods, e.g. by roasting or frying using wave energy, irradiation, electrical means or magnetic fields, e.g. oven cooking or roasting using radiant dry heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 특정 진세노사이드의 함량이 증가된 인삼 및 그의 제조방법에 관한 것으로서, 보다 구체적으로는 C-Mx1, Rg4, Rg5, Rg6, Rh4, Rk1, Rk3, F2, The present invention relates to ginseng having an increased content of certain ginsenosides and a method for producing the ginseng. More specifically, the present invention relates to a ginseng having a specific ginsenoside content of at least one of ginsenoside R, ginsenoside R, ginsenoside R,
또는 C-Mc 성분의 함량이 증가된 진세노사이드 및 그의 제조방법에 관한 것이다.Or C-Mc component, and a process for producing the same.
건강한 삶에 대한 욕구와 편이성 추구라는 현대인의 생활양식의 변화에서 소비자의 요구가 다양해지고 시장에서 보지 못한 제품에 대한 새로운 요구(unmet needs)가 높아지고 있다. 인삼류는 전통적으로 명약에 속하는 약물로서 단점으로는 장기간 보관이 어렵고, 냉장보관을 하여도 곰팡이에 의하여 품질변화를 일으켜 제품의 질을 떨어뜨리게 된다. 심지어 냉동상태에서도 녹색곰팡이가 자라는 현상으로 장기보존이 어렵다.Demand for healthy life and the pursuit of convenience have changed the lifestyle of modern people. Consumer demands have changed and unmet needs for products that have not been seen in the market are increasing. Traditionally, Ginseng is a drug belonging to Shiraku, and its disadvantage is that it is difficult to store for a long time and even if it is stored in a refrigerator, the quality of the product is deteriorated by causing a change in quality due to mold. Long-term preservation is difficult due to the growth of green fungi even in the frozen state.
인삼류는 오갈피과 식물에 속하는 다년생 숙근초로서, 주로 살이 많은 뿌리를 약용으로 쓰는 식물이며, 근래에는 줄기와 잎 나아가 종자까지 활용하게 되었다.Ginseng is a perennial herbaceous perennial plant belonging to the family Acanthopanax senticosus. It is mainly used for medicinal purposes with many roots. In recent years, it has also utilized stem and leaf seeds.
천종산삼은 천연 산삼의 종자가 산림내의 자연환경 속에서 자연적으로 발아하여 번식생육한 삼을 말하며, 산양삼은 산삼의 종자를 산 속에 파종하여 자연 상태 그대로 자생시킨 삼을 말한다. 또한 인삼은 밭에서 사람에 의하여 재배되는 삼을 말한다. 화기삼은 캐나다나 미국 등에서 재배된 삼을 말하며, 전칠삼은 주로 중국에서 재배된 삼을 말한다. 또한 액체 배양에 의하여 일정한 조건의 배양조에서 생육된 삼을 배양근이라고 한다. 이것은 반복생산에 의하여 성질이 변하는 단점이 있고 오염의 가능성이 높다.The seeds of the wild ginseng are sprouted and grown by naturally germinating in the natural environment in the forest, and the goat ginseng refers to the seeds of wild ginseng sown in the mountains and grown in the natural state. Also, ginseng is grown by man in the field. Firewood is grown in Canada and the United States, and the former is mainly grown in China. It is also called as a cultivar which is grown in a culture tank under constant conditions by liquid culture. This has the disadvantage that properties are changed by repetitive production and there is a high possibility of contamination.
인삼, 산삼과 산양삼의 학명은 모두 Panax ginseng C.A. Mayer로 어원을 보면 ‘Pan’은 ‘모든 것’, ‘Axos’는 ‘의학’ 이라는 뜻으로 '만병 통치’라는 의미를 가진다. 산삼과 산양삼은 유효성분의 종류가 다양하고 함량도 풍부하여 고가로 거래되고 있지만 가공되지 않은 산삼의 경우에는 일반적으로 1주일 이상의 보관이 어렵기 때문에 산삼 자체로 상품화하기가 쉽지 않다. 또한 냉동보관을 하더라도 뿌리 내 또는 뿌리의 표피에 존재하는 곰팡이가 천천히 자라면서 가치를 떨어뜨리게 된다. 따라서 기존의 과학적 연구는 주로 인삼의 약리효능 및 성분에 초점을 맞춰 진행되어왔으며 산삼의 희소성 가치 때문에 산삼에 대한 약리효능 및 생리학적 연구가 체계적으로 확립되지 못한 실정이다.The scientific names of ginseng, wild ginseng and goat ginseng are Panax ginseng C.A. When you look at the etymology of Mayer, 'Pan' means 'everything', 'Axos' means 'medicine' and means 'panacea.' Wild ginseng and goat ginseng are traded at a high price because of the variety of active ingredients and their rich contents. However, in case of unprocessed ginseng, it is generally difficult to store more than one week. Even frozen storage will slow the growth of fungi in the roots or on the epidermis of the roots, reducing their value. Therefore, the existing scientific research has focused mainly on the pharmacological effects and components of ginseng, and pharmacological effects and physiological studies on ginseng have not been systematically established due to the scarcity value of ginseng.
최근에 산삼을 자연에서 재배한 산양삼이 많이 재배되고 있고, 따라서 이 산양삼의 고급화, 산업화가 절실한 시점에 와 있다. 산양삼에 들어있는 인삼사포닌 및 비 사포닌계 물질(파나센, 다당류, 아미노산 유도체, 폴리아세틸렌 유도체, 페놀화합물)은 뛰어난 약리활성을 가지며, 유해 활성산소(free radical)소거에 탁월한 효능을 가지며 항산화, 항암, 혈압강하, 지질강하, 간독성 경감, 시장보호, 근력강화, 기억력개선 등에 뛰어난 효능을 지닌다. 특히 신장기능 강화에 특별한 효능이 있다고 알려져 왔다.Recently, there has been a lot of goat ginseng cultivated in nature in the mountains, and therefore the quality and industrialization of these goat ginsengs are at a critical stage. Ginseng saponin and non saponin substances (panaceans, polysaccharides, amino acid derivatives, polyacetylene derivatives, phenolic compounds) contained in goat ginseng have excellent pharmacological activity, excellent efficacy in eliminating free radicals, antioxidant, anti-cancer , Blood pressure lowering, lipid lowering, hepatotoxicity reduction, market protection, strengthening muscle strength, improvement of memory. Especially, it has been known that there is a special effect on strengthening kidney function.
인삼의 주요 약리성분 잘 알려진 사포닌은 프로토파낙사디올계(Proto panaxadiol)와, 프로토파낙사트리올계(Proto panaxatriol)로 나누어진다. 즉, 기본구조에 따라서 피피티(PPT) 계열의 사포닌과 피피디(PPD) 계열의 사포닌으로 대표되는 구조를 함유하고 있다. 산양삼은 진세노사이드들(ginsenosides)의 함량이 일반 인삼에 비해 최대 3 ~ 4배 더 높은 것으로 알려져 있고, 그 중 특히 프로토파낙사디올계(Proto panaxadiol)의 Rg3(20-Sprotopanaxadiol-3-[O-D-glucopyranosyl (1,2)-glucopyranoside])는 혈소판 응집 억제 효과, 전립성 암 세포 증식 억제, 기억력증가 및 신경보호효과, 간독성 경감 등의 다양한 약리 효능을 가진다.The main pharmacological components of ginseng are well known saponins, which are divided into proto panaxadiol and proto panaxatriol. That is, it contains a structure represented by saponins of PPT (sapphire) series and PPD (sapphire) series according to the basic structure. It is known that the ginsenosides content of the goat ginseng is 3 to 4 times higher than that of the common ginseng. Especially, the content of protopanaxadiol Rg3 (20-Sprotopanaxadiol-3- [OD -glucopyranosyl (1,2) -glucopyranoside) has various pharmacological effects such as an inhibitory effect on platelet aggregation, an inhibition of proliferation of prostate cancer cells, an increase in memory and neuroprotective effect, and a reduction in hepatotoxicity.
따라서 이러한 진세노사이드의 기능 및 함량이 강화된 산양삼 및 인삼의 개발이 요구 되어지고 있으며, 최근 들어 인삼을 가공하여 인삼의 특정 약효나 유용성을 변화시키려는 노력이 시도되고 있다. 특히 본 발명자들은, 산양삼 등의 제품을 가공하는 공정 중에서 진세노사이드의 구조가 변화하면서 기존에 존재하지 않았던 다양한 진세노사이드가 생성되고 그 함량이 증가되는 것을 발견하였다. Therefore, development of goat ginseng and ginseng having enhanced functions and contents of ginsenoside has been demanded. Recently, attempts have been made to change ginseng's specific efficacy and usefulness by processing ginseng. In particular, the present inventors have found that various ginsenosides, which have not existed in the past, are produced and the content thereof is increased in the process of processing products such as goat ginseng.
상기의 종래 문제점을 해결하고자, 본 발명은 다양한 종류의 특정 진세노사이드의 함량이 증가된 인삼 제조방법 및 그로부터 제조된 인삼을 제공하고자 한다.In order to solve the above-mentioned problems, the present invention provides a ginseng production method in which various kinds of specific ginsenosides are increased in content and ginseng produced therefrom.
또한, 본 발명은 식감, 향 등 기호도가 우수하고 저장성이 증가된 인삼 및 그의 제조방법을 제공하고자 한다. In addition, the present invention provides ginseng having excellent taste and texture such as texture, flavor and shelf life, and a process for producing the ginseng.
본 발명의 제1 양태는 In a first aspect of the present invention,
수삼을 절편하는 단계; 및Cutting the fresh ginseng; And
상기 절편된 수삼을 150℃ 내지 200℃에서 열처리하는 단계를 포함하는, C-Mx1, Rg4, Rg5, Rg6, Rh4, Rk1, Rk3, F2 및 C-Mc로 이루어진 군에서 선택된 하나 이상의 진세노사이드 함량이 증가된 인삼의 제조방법을 제공한다.The method according to any one of claims 1 to 3, further comprising the step of heat-treating the sectioned fresh ginseng at 150 to 200 占 폚, wherein the content of at least one ginsenoside selected from the group consisting of C-Mx1, Rg4, Rg5, Rg6, Rh4, Rk1, Rk3, F2 and C- Thereby providing an increased production method of ginseng.
또한, 본 발명의 제2 양태는 제1 양태에 의해 제조된, C-Mx1, Rg4, Rg5, Rg6, Rh4, Rk1, Rk3, F2 및 C-Mc로 이루어진 군에서 선택된 하나 이상의 진세노사이드를 포함하는 인삼을 제공한다.The second aspect of the present invention also includes a composition comprising at least one ginsenoside selected from the group consisting of C-Mx1, Rg4, Rg5, Rg6, Rh4, Rk1, Rk3, F2 and C- Ginseng.
나아가, 본 발명의 제3 양태는 제2 양태에 따른 인삼을 포함하는 건강기능식품을 제공한다.Furthermore, the third aspect of the present invention provides a health functional food comprising ginseng according to the second aspect.
이하, 본 발명을 보다 상세하게 설명한다.Hereinafter, the present invention will be described in more detail.
본 명세서에서 수삼은 건조되지 않은 인삼을 의미하며, 인삼은 학명이 Panax ginseng C.A. Mayer에 속하는 것이면 제한없이 모두 사용 가능하며, 재배된 삼인지 천연삼인지 구별하지 않는다. In the present specification, fresh ginseng refers to ginseng that has not been dried, and ginseng has a scientific name of Panax ginseng C.A. Anything belonging to Mayer can be used without limitation, and it does not distinguish between cultivated or natural.
수삼을 절편하는 단계에서, 절편된 수삼의 두께는 평균입경 0.5 내지 1cm 크기일 수 있다. 절편 두께가 너무 두꺼우면 수삼 내부로 열 전달이 잘 안되고, 두께가 너무 얇으면 열처리 과정 중에 쉽게 타버리는 문제가 발생할 수 있다.In the step of cutting the fresh ginseng, the thickness of the cut ginseng may be 0.5-1 cm in average particle size. If the slice thickness is too thick, the heat transfer to the ginseng can not be performed well, and if the thickness is too thin, it may easily burn down during the heat treatment process.
또한, 절편된 수삼을 150℃ 내지 200℃에서 열처리하는 단계는 고온의 공기 순환장치에서 가열하는 과정일 수 있다. 열처리하는 온도 조건이 150℃ 미만인 경우에는 특정 진세노사이드로의 변환이 원활히 이루어지지 않으며, 온도 조건이 200℃를 초과하는 경우에는 수삼이 타버리는 문제가 발생할 수 있다. In addition, the step of heat-treating the cut ginseng at 150 ° C to 200 ° C may be a step of heating in a high-temperature air circulating apparatus. If the temperature condition for the heat treatment is less than 150 ° C, the conversion to a specific ginsenoside is not smoothly performed. If the temperature condition exceeds 200 ° C, the problem may occur that the ginseng is burnt.
또한, 열처리 시간은 3분 내지 10분일 수 있다. 3분 미만인 경우에는 시간이 충분하지 않아 특정 진세노사이드로의 변환이 원활히 이루어지지 않으며, 10분 초과인 경우에는 수삼이 타버리는 문제가 발생할 수 있다. The heat treatment time may be 3 minutes to 10 minutes. If the time is less than 3 minutes, the time is not sufficient and the conversion to a specific ginsenoside is not smoothly performed. If the time is longer than 10 minutes, ginseng may be burned.
본 발명의 열처리하는 단계는, 고온의 공기 순환에 의해 열이 전달됨으로써, 수삼에 골고루 열을 전달할 수 있으며, 10분 이하의 짧은 시간에 다양한 진세노사이드를 포함하는 인삼을 제조할 수 있다. 통상 진세노사이드의 구조가 변화하면서 기존에 존재하지 않았던 다양한 진세노사이드가 생성되거나 진세노사이드의 함량을 증가시키기 위해서는, 최소 2~3시간 동안의 증숙 과정이 필요하며, 이를 제품화하기 위해서는 별도의 건조 과정도 필요하다. 반면, 본 발명의 인삼 제조방법은 고온의 공기를 사용한 열처리 방법을 사용함으로써, 추가적인 건조 과정이 필요하지 않는다.In the heat treatment step of the present invention, heat can be transferred to the fresh ginseng by heat transfer by high-temperature air circulation, and ginseng containing various ginsenosides can be produced in a short time of 10 minutes or less. Generally, in order to increase the content of ginsenosides or to produce various ginsenosides which have not existed due to the change of the structure of ginsenoside, it is necessary to perform a steaming process for at least 2 to 3 hours. Drying process is also necessary. On the other hand, the ginseng manufacturing method of the present invention does not require an additional drying process by using the heat treatment method using high temperature air.
일 실시형태에서, 열처리는 챔버 한쪽에 열을 내는 코일이 있고, 바람을 불어 넣어 그 뜨거운 공기가 챔버 안에서 계속 순환되는 형태로 이루어질 수 있다.In one embodiment, the heat treatment can be in the form of a coil having heat on one side of the chamber and blowing in to keep the hot air circulating in the chamber.
구체적으로 본 발명의 제조방법은 C-Mx1(compound Mx1), Rg4 (CAS No. 126223-28-7), Rg5 (CAS No. 74964-14-0), Rg6 (CAS No. 147419-93-0), Rh4 (CAS No. 174721-08-5), Rk1 (CAS No. 494753-69-4), Rk3 (CAS No. 364779-15-7), F2 (CAS No. 62025-49-4) 및 C-Mc (compound Mc)로 이루어진 군에서 선택된 하나의 진세노사이드를 포함하는 인삼을 제조할 수 있다. 상기 특정 진세노사이드는 가공하기 전의 상태인 수삼의 상태에서는 내포되어 있지 않거나 내포되어 있더라도 극미량만 포함되어 있다. Specifically, the production method of the present invention is characterized in that C-Mx1 (compound Mx1), Rg4 (CAS No. 126223-28-7), Rg5 (CAS No. 74964-14-0), Rg6 (CAS No. 147419-93-0 ), Rh4 (CAS No. 174721-08-5), Rk1 (CAS No. 494753-69-4), Rk3 (CAS No. 364779-15-7), F2 (CAS No. 62025-49-4) and C-Mc (compound Mc), can be prepared. The specific ginsenosides are not contained in the state of fresh ginseng before processing, or contained only trace amounts even if contained.
일 실시형태에서, 제조된 인삼은 C-Mx1 0.01 내지 40.0 mg/kg, Rg4 0.01 내지 60.0 mg/kg, Rg5 0.01 내지 170.0 mg/kg, Rg6 0.01 내지 50.0 mg/kg, Rh4 0.01 내지 200.0 mg/kg, Rk1 0.01 내지 150.0 mg/kg, Rk3 0.01 내지 80.0 mg/kg, F2 0.01 내지 30.0 mg/kg, 및/또는 C-Mc 0.01 내지 30.0 mg/kg를 포함할 수 있다. In one embodiment, the ginseng produced comprises 0.01 to 40.0 mg / kg of C-Mx1, 0.01 to 60.0 mg / kg of Rg4, 0.01 to 170.0 mg / kg of Rg5, 0.01 to 50.0 mg / kg of Rg6, 0.01 to 200.0 mg / kg of Rh4 0.01 to 150.0 mg / kg of Rk1, 0.01 to 80.0 mg / kg of Rk3, 0.01 to 30.0 mg / kg of F2, and / or 0.01 to 30.0 mg / kg of C-Mc.
진세노사이드 성분 F2 및 Rk1은 암세포의 증식을 억제하는 효과가 있는 것으로 알려져 있다. 또한, Rh4는 항암, 간장보호, 항유리기 작용을 할 수 있으며, Rg4는 심장보호, 기억력 향상, 항혈전, 항유리기 작용을 할 수 있으며, Rg5는 항혈전, 항암, 기억력 제고, 항유리기 작용을 할 수 있다.The ginsenoside components F2 and Rk1 are known to have the effect of inhibiting the proliferation of cancer cells. In addition, Rh4 may have anticancer, hepatoprotective, anti-free radical function, and Rg4 may play a role in cardioprotection, memory improvement, anti-thrombosis, anti-freezing and Rg5 is antithrombotic, anticancer, can do.
본 발명에 의해 제조된 인삼은 가공되기 전의 수삼에 비해 감소된 수분 함량을 가지며, 그로 인해 저장성을 높일 수 있다. 일 실시형태에서, 제조된 인삼은 인삼 총 중량 기준으로 15 중량% 미만의 수분을 함유할 수 있다.The ginseng produced by the present invention has a reduced moisture content as compared with that of fresh ginseng before it is processed, thereby enhancing storage stability. In one embodiment, the ginseng produced may contain less than 15% by weight of water based on the total weight of ginseng.
또한, 인삼의 풍미와 기호도가 증가되어 인삼에 대한 거부감을 감소시키고, 건강기능식품, 의약품 등 다양한 형태로 응용될 수 있다.In addition, the flavor and taste of ginseng is increased to reduce the resistance to ginseng, and it can be applied to various forms such as health functional foods and medicines.
"건강기능식품"이란, 특정보건용 식품(food for special health use, FoSHU)와 동일한 용어로, 영양 공급 외에도 생체조절기능이 효율적으로 나타나도록 가공된 의학, 의료효과가 높은 식품을 의미하며, 경우에 따라 건강식품, 기능성식품, 건강보조식품 등의 용어와 혼용될 수 있다.The term "health functional food" is the same term as "food for special health use" (FoSHU). In addition to nutritional support, May be used in combination with terms such as health foods, functional foods, and health supplements.
건강기능식품의 제품 형태는 바람직하게는 정제, 캅셀, 분말, 과립, 액상, 환 등의 다양한 형태로 제조될 수 있으나, 특별히 이에 제한되지는 않는다. 본 발명의 인삼이 식품 첨가물로 사용할 경우, 인삼을 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효 성분의 혼합양은 사용 목적(예방, 건강 또는 치료적 처치)에 따라 적합하게 결정될 수 있다.The product form of the health functional food may be prepared in various forms such as tablets, capsules, powders, granules, liquids, and rings, but is not particularly limited thereto. When the ginseng of the present invention is used as a food additive, ginseng can be added as it is, or it can be used together with other food or food ingredients, and can be suitably used according to a conventional method. The amount of the active ingredient to be mixed can be suitably determined according to the intended use (prevention, health or therapeutic treatment).
상기 식품의 종류에는 특별한 제한은 없다. 인삼을 첨가할 수 있는 식품의 예로는 육류, 소세지, 빵, 쵸코렛, 캔디류, 스넥류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알코올 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 건강식품을 모두 포함한다.There is no particular limitation on the kind of the food. Examples of foods to which ginseng can be added include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gums, dairy products including ice cream, various soups, drinks, tea, Beverages, and vitamin complexes, all of which include health foods in a conventional sense.
상기 외에 본 발명의 건강기능식품은 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드, 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있다. 그밖에 본 발명의 건강기능식품은 천연 과일쥬스,In addition to the above, the health functional food of the present invention may contain various nutrients, vitamins, electrolytes, flavors, colorants, pectic acid and salts thereof, alginic acid and salts thereof, organic acids, protective colloids, thickeners, pH adjusting agents, stabilizers, , Alcohols, carbonating agents used in carbonated drinks, and the like. In addition, the health functional food of the present invention may contain natural fruit juice,
과일쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다.Fruit juice beverages and pulp for the production of vegetable beverages.
본 발명의 인삼의 제조방법은 가공하기 전에는 존재하지 않았거나 극미량만 존재했던 특정 진세노사이드의 함량이 증가된 인삼을 제공할 수 있으며, 본 발명에 의해 제조된 인삼은 가공되기 전의 수삼에 비해 감소된 수분 함량을 가지며, 그로 인해 저장성을 높일 수 있다.The ginseng method of the present invention can provide ginseng having a specific ginsenoside content which was not present before or was only present in a very small amount, and the ginseng produced by the present invention is reduced Water content, thereby increasing storage stability.
또한, 인삼의 풍미와 기호도가 증가되어 인삼에 대한 거부감을 감소시키고, 건강기능식품, 의약품 등 다양한 형태로 응용될 수 있다. In addition, the flavor and taste of ginseng is increased to reduce the resistance to ginseng, and it can be applied to various forms such as health functional foods and medicines.
이하, 실시예를 통하여 본 발명을 보다 상세히 설명하고자 한다. 이들 실시예는 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are for further illustrating the present invention, and the scope of the present invention is not limited to these examples.
실시예Example 1 One
건조되지 않은 수삼을 일정한 크기로 절편한 후, 약 200℃의 공기 순환장치에서 약 10분간 열처리를 하였다. 상기 공기순환장치는 챔버 한쪽에 열을 내는 코일이 있고 바람을 불어 넣어 그 뜨거운 공기가 챔버 안에서 계속 순환되는 구조이다.The non-dried ginseng was sectioned to a predetermined size and heat-treated in an air circulating apparatus at about 200 ° C for about 10 minutes. The air circulation device has a coil which generates heat on one side of the chamber, and blows air to continuously circulate the hot air in the chamber.
실험예Experimental Example
1. 인삼의 풍미와 1. The flavor of ginseng 식감Texture
가공하지 않은 수삼(비교예)과 실시예 1의 인삼에 대해, 관능검사 요원(20명)을 대상으로 하여 향, 쓴맛 등 종합적인 기호도를 5점 척도법으로 측정하였다. 각 항목별로 특성이 강할수록 5점을, 약할수록 1점으로 기록하였다. 각 항목별 점수의 평균값을 기호도에 기재하였다.For the untreated fresh ginseng (Comparative Example) and the ginseng of Example 1, sensory evaluation test (20 persons) were evaluated for their overall preference such as aroma and bitterness by the five point scaling method. As the characteristics of each item were stronger, it was recorded as 5 points. The average value of the score for each item is shown in the symbol.
(200℃, 10min) Example 1
(200 DEG C, 10 min)
그 결과, 실시예 1의 인삼은 가공하지 않은 수삼인 비교예에 비해, 특유한 향은 감소하고, 구수한 향은 증가한 반면에 인삼 특유의 쓴맛은 감소하여, 전반적으로 기호도가 증가하였다.As a result, the ginseng of Example 1 was reduced in peculiar flavor and increased in fragrance, while the bitterness peculiar to ginseng was reduced compared to the comparative example of raw ginseng, which was not processed, and overall taste was increased.
2. 진세노사이드 성분의 변화2. Changes in the components of ginsenosides
가공하지 않은 수삼(비교예)과 실시예 1의 인삼에 대해, 진세노사이드 C-Mx1, Rg4, Rg5, Rg6, Rh4, Rk1, Rk3, F2 및 C-Mc 성분이 존재하는지 여부를 검사하였으며, LC-MS/MS를 사용하여 각 진세노사이드 성분의 분자량을 확인하고 각각 정량하여 하기 값을 얻었다.The ginsenosides C-Mx1, Rg4, Rg5, Rg6, Rh4, Rk1, Rk3, F2 and C-Mc components were examined for untreated ginseng (comparative example) and the ginseng of Example 1, The molecular weight of each ginsenoside component was determined using LC-MS / MS and quantified to obtain the following values.
(단위: mg/kg)sample
(Unit: mg / kg)
(200℃, 10min) Example 1
(200 DEG C, 10 min)
그 결과, 가공하지 않은 수삼인 비교예에서는 진세노사이드 C-Mx1, Rg4, Rg5, Rg6, Rh4, Rk1, Rk3, F2 및 C-Mc 성분이 모두 검출되지 않은 반면에, 열처리를 통해 가공된 실시예 1의 인삼에서는 상기 진세노사이드 성분들이 모두 다량으로 검출되었다. 즉, 열처리를 통해서 종래 존재하였던 진세노사이드의 구조가 변화하여서, 새로운 구조의 특정 진세노사이드가 생성 되었음이 확인되었다. As a result, the ginsenosides C-Mx1, Rg4, Rg5, Rg6, Rh4, Rk1, Rk3, F2 and C-Mc components were not detected in the comparative example in which raw ginseng was not processed, In the ginseng of Example 1, all of the ginsenoside components were detected in a large amount. That is, it was confirmed that the structure of ginsenoside, which had existed through heat treatment, changed, and a specific ginsenoside of a new structure was generated.
3. 수분 함량 변화3. Change in moisture content
가공하지 않은 수삼(비교예)과 실시예 1의 인삼의 수분함량을 측정한 결과, 비교예는 78.0%의 수분을, 실시예 1은 12.8%의 수분을 함유하고 있었다. 즉, 고온의 열처리를 통해서 실시예 인삼의 수분 함량은 크게 감소하였다. 상기 수분함량 측정은 시료(비교예 및 실시예 1)를 드라이오븐에 넣고 60℃로 유지하면서 그 무게가 변하지 않을 때까지 건조한 후 그 무게를 측정하여 건조 전/후를 비교하여 측정하였다. The water content of untreated ginseng (Comparative Example) and the ginseng of Example 1 were measured. As a result, the comparative example contained 78.0% of water and Example 1 contained 12.8% of water. That is, the water content of the ginseng of the present invention was greatly reduced through the high temperature heat treatment. The moisture content was measured by comparing the weight of the sample (Comparative Example and Example 1) before and after drying after the sample was kept in a dry oven at 60 캜 while drying the weight until the weight was not changed.
Claims (8)
상기 절편된 수삼을 150℃ 내지 200℃에서 열처리하는 단계를 포함하는, C-Mx1, Rg4, Rg5, Rg6, Rh4, Rk1, Rk3, F2 및 C-Mc로 이루어진 군에서 선택된 하나 이상의 진세노사이드 함량이 증가된 인삼의 제조방법.
Cutting the fresh ginseng; And
The method according to any one of claims 1 to 3, further comprising the step of heat-treating the sectioned fresh ginseng at 150 to 200 占 폚, wherein the content of at least one ginsenoside selected from the group consisting of C-Mx1, Rg4, Rg5, Rg6, Rh4, Rk1, Rk3, F2 and C- Thereby increasing the production method of ginseng.
상기 절편하는 단계는 수삼을 평균입경 0.5 내지 1cm 크기로 절편하는 것인, 인삼의 제조방법.
The method according to claim 1,
Wherein the sectioning step comprises cutting the fresh ginseng to an average particle size of 0.5 to 1 cm.
상기 열처리하는 단계는 3분 내지 10분 동안 열처리하는 것인, 인삼의 제조방법.
The method according to claim 1,
Wherein the heat treatment step is a heat treatment for 3 minutes to 10 minutes.
상기 열처리하는 단계는 공기의 순환에 의해 열이 전달되는 것인, 인삼의 제조방법.
The method according to claim 1,
Wherein the step of heat-treating comprises transferring heat by circulation of air.
상기 인삼은 인삼 총 중량 기준으로 15 중량% 미만의 수분을 포함하는 것인, 인삼의 제조방법.
The method according to claim 1,
Wherein the ginseng comprises less than 15% by weight of water based on the total weight of the ginseng.
상기 인삼은 C-Mx1 0.01 내지 40.0 mg/kg, Rg4 0.01 내지 60.0 mg/kg, Rg5 0.01 내지 170.0 mg/kg, Rg6 0.01 내지 50.0 mg/kg, Rh4 0.01 내지 200.0 mg/kg, Rk1 0.01 내지 150.0 mg/kg, Rk3 0.01 내지 80.0 mg/kg, F2 0.01 내지 30.0 mg/kg, 또는 C-Mc 0.01 내지 30.0 mg/kg를 포함하는 것인, 인삼의 제조방법.
The method according to claim 1,
Wherein the ginseng comprises 0.01 to 40.0 mg / kg of C-Mx1, 0.01 to 60.0 mg / kg of Rg4, 0.01 to 170.0 mg / kg of Rg5, 0.01 to 50.0 mg / kg of Rg6, 0.01 to 200.0 mg / kg of Rh4, 0.01 to 150.0 mg of Rk1 / kg, Rk3 0.01 to 80.0 mg / kg, F2 0.01 to 30.0 mg / kg, or C-Mc 0.01 to 30.0 mg / kg.
At least one ginsenoside selected from the group consisting of C-Mx1, Rg4, Rg5, Rg6, Rh4, Rk1, Rk3, F2 and C-Mc prepared according to any one of claims 1 to 6 Ginseng.
A health functional food comprising ginseng according to claim 7.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160137742A KR20180044091A (en) | 2016-10-21 | 2016-10-21 | Ginseng containing increased specific ginsenoside and the preparing method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160137742A KR20180044091A (en) | 2016-10-21 | 2016-10-21 | Ginseng containing increased specific ginsenoside and the preparing method thereof |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190040404A Division KR20190039495A (en) | 2019-04-05 | 2019-04-05 | Ginseng containing increased specific ginsenoside and the preparing method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20180044091A true KR20180044091A (en) | 2018-05-02 |
Family
ID=62183759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160137742A KR20180044091A (en) | 2016-10-21 | 2016-10-21 | Ginseng containing increased specific ginsenoside and the preparing method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20180044091A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200117750A (en) | 2019-04-05 | 2020-10-14 | 김영주 | Ginseng Jung Kwa comprising physiological active substance of Palmyra Palm and Artichoke and manufacturing method thereof |
KR20200117749A (en) | 2019-04-05 | 2020-10-14 | 김영주 | Food composition comprising Palmyra Palm, Ginseng, and Artichoke as an active ingredient and manufacturing method thereof |
KR20200117751A (en) | 2019-04-05 | 2020-10-14 | 김영주 | Foaming tablet comprising Palmyra Palm, Ginseng and Artichoke and manufacturing method thereof |
KR20220037303A (en) | 2020-09-17 | 2022-03-24 | 주식회사 비엔지삶 | Food composition comprising Palmyra Palm and Ginseng as an active ingredient and manufacturing method thereof |
KR20220122867A (en) | 2021-02-26 | 2022-09-05 | 주식회사 비엔지삶 | Food composition comprising Borassus Flabellifer as an active ingredient and manufacturing method thereof |
KR20230032479A (en) | 2021-08-31 | 2023-03-07 | 보령해삼영어조합법인 | Food composition comprising Trepang and Herb extracts as an active ingredient and manufacturing method thereof |
-
2016
- 2016-10-21 KR KR1020160137742A patent/KR20180044091A/en active Search and Examination
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200117750A (en) | 2019-04-05 | 2020-10-14 | 김영주 | Ginseng Jung Kwa comprising physiological active substance of Palmyra Palm and Artichoke and manufacturing method thereof |
KR20200117749A (en) | 2019-04-05 | 2020-10-14 | 김영주 | Food composition comprising Palmyra Palm, Ginseng, and Artichoke as an active ingredient and manufacturing method thereof |
KR20200117751A (en) | 2019-04-05 | 2020-10-14 | 김영주 | Foaming tablet comprising Palmyra Palm, Ginseng and Artichoke and manufacturing method thereof |
KR20220037303A (en) | 2020-09-17 | 2022-03-24 | 주식회사 비엔지삶 | Food composition comprising Palmyra Palm and Ginseng as an active ingredient and manufacturing method thereof |
KR20220122867A (en) | 2021-02-26 | 2022-09-05 | 주식회사 비엔지삶 | Food composition comprising Borassus Flabellifer as an active ingredient and manufacturing method thereof |
KR20230032479A (en) | 2021-08-31 | 2023-03-07 | 보령해삼영어조합법인 | Food composition comprising Trepang and Herb extracts as an active ingredient and manufacturing method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rashwan et al. | Jujube fruit: A potential nutritious fruit for the development of functional food products | |
KR20180044091A (en) | Ginseng containing increased specific ginsenoside and the preparing method thereof | |
CN103156896B (en) | Preparation method for novel red ginseng using reduced-pressure drying after high temperature high pressure process | |
KR20120114632A (en) | Manggae rice cake composition and the method of preparation thereof | |
CN106307268A (en) | Production method of pickled garlic rich in tea polyphenols | |
KR101693361B1 (en) | Cudrania tricupspidate drinks comprising cudrania tricupspidate extract and method for manufacturing thereof | |
KR20170026307A (en) | Manufacturing process for rice syrup by using ginseng, Platycodon grandiflorum or Codonopsis lanceolata | |
KR101481866B1 (en) | Method for manufacturing wonso-byung, and wonso-byung manufactured by the same | |
KR102129253B1 (en) | Wasabi paste and manufacturing method for the same | |
KR20190039495A (en) | Ginseng containing increased specific ginsenoside and the preparing method thereof | |
KR101346364B1 (en) | Method for producing Dangmyen with enhanced antioxidative activity adding purple sweet potato and Dangmyen produced by the same method | |
KR20180078658A (en) | Composition for Health Containing Ginseng Extract | |
KR102002080B1 (en) | Method for producing glutinous rice cake using persimmon, grain and medicinal plant | |
KR100894537B1 (en) | A manufacturing method of jelly using a bokbunja | |
KR101838061B1 (en) | Method for producing sauce for rice | |
KR100836458B1 (en) | The method of the psidium guava functional food | |
KR101793700B1 (en) | fish paste composition improved storage periods comprising natural complex extract | |
KR101402600B1 (en) | Instant noodle manufacturing methods | |
KR101522960B1 (en) | Manufacturing method of Kimchi containing Liriope platyphylla and Kimchi containing Liriope platyphylla manufactured by the same | |
KR20160119920A (en) | Antioxidant and anti-diabetic composition comprising cowpea and Helianthus tuberosus and method thereof | |
KR20160068014A (en) | Cudrania tricupspidate drinks comprising cudrania tricupspidate extract and method for manufacturing thereof | |
KR101863340B1 (en) | Mulberry soy sauce and preparation method thereof | |
KR101719057B1 (en) | A Beverage Containing Extract and Slice of Spend Mushroom (Flammulina Velutipes) and A Method For Preparing Thereof | |
JP2006006317A (en) | Taste-modifying agent | |
CN111213802A (en) | Momordica grosvenori ginger beverage and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment |